Orion Group Holdings Launches Consortium to Secure Critical Mineral Supply Chains

Orion Group Holdings Champions Critical Mineral Supply Chain Security

Orion Group Holdings makes significant strides in the critical minerals sector with the launch of the Orion Critical Mineral Consortium (Orion CMC), aimed at bolstering supply chain resilience for essential resources vital to economic growth and national security. Announced on October 23, 2025, the consortium is a strategic collaboration with the U.S. International Development Finance Corporation (DFC) and notable investors in metals and mining. With an initial capital commitment of $1.8 billion, Orion CMC sets ambitious goals of reaching a $5 billion target, backed by both Orion and sovereign investor ADQ. This initiative underscores Orion's commitment to addressing the urgent demand for critical minerals, which are foundational for sectors such as advanced manufacturing and artificial intelligence.

The consortium is determined to prioritize investments in existing or nearly operational projects rather than long-term exploration endeavors. This approach aims to meet immediate market needs while enhancing domestic processing capabilities and scaling cost-effective technologies for mineral extraction. As global supply chains face increasing pressures, Orion CMC's strategic focus on critical minerals positions the company as a leader in addressing these challenges, fostering innovation, and ensuring a reliable supply of resources that are integral to the economy.

Oskar Lewnowski, Founder and CEO of Orion, emphasizes that Orion CMC represents a pivotal step towards bridging the gap between emerging market nations and global consumers. This initiative not only reinforces Orion's position in the critical minerals landscape but also aligns with the broader objectives of securing supply chains for vital materials that support national and allied interests. The consortium’s efforts reflect a growing recognition of the strategic importance of critical minerals in the modern economy, particularly as nations strive for technological advancement and economic independence.

In addition to the formation of Orion CMC, Orion Group Holdings also strengthens its oncology pipeline through a partnership with Abzena, a leading Contract Development and Manufacturing Organization. The collaboration grants Orion an exclusive commercial license for a monoclonal antibody targeting significant unmet needs in cancer treatment, enhancing its research and development capabilities. This partnership showcases Orion's commitment to addressing pressing healthcare challenges while further diversifying its portfolio.

Overall, Orion Group Holdings is positioning itself as a vital player in both the critical minerals and healthcare sectors, reinforcing its dedication to innovation and strategic partnerships that meet the demands of the modern economy and society.